Logo image of ALTI

ALTI GLOBAL INC (ALTI) Stock Fundamental Analysis

NASDAQ:ALTI - Nasdaq - US02157E1064 - Common Stock - Currency: USD

3.28  -0.01 (-0.3%)

After market: 3.28 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALTI. ALTI was compared to 225 industry peers in the Capital Markets industry. While ALTI seems to be doing ok healthwise, there are quite some concerns on its profitability. ALTI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALTI had negative earnings in the past year.
In the past year ALTI has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: ALTI reported negative net income in multiple years.
Of the past 5 years ALTI 4 years had a positive operating cash flow.
ALTI Yearly Net Income VS EBIT VS OCF VS FCFALTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.27%, ALTI is doing worse than 85.84% of the companies in the same industry.
Looking at the Return On Equity, with a value of -12.47%, ALTI is doing worse than 83.56% of the companies in the same industry.
Industry RankSector Rank
ROA -6.27%
ROE -12.47%
ROIC N/A
ROA(3y)-4.66%
ROA(5y)N/A
ROE(3y)-23.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALTI Yearly ROA, ROE, ROICALTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALTI Yearly Profit, Operating, Gross MarginsALTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 100

4

2. Health

2.1 Basic Checks

ALTI has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ALTI has been reduced compared to a year ago.
ALTI Yearly Shares OutstandingALTI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
ALTI Yearly Total Debt VS Total AssetsALTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

ALTI has an Altman-Z score of 0.42. This is a bad value and indicates that ALTI is not financially healthy and even has some risk of bankruptcy.
ALTI has a worse Altman-Z score (0.42) than 72.15% of its industry peers.
ALTI has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
ALTI has a Debt to Equity ratio of 0.18. This is in the better half of the industry: ALTI outperforms 78.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 0.42
ROIC/WACCN/A
WACCN/A
ALTI Yearly LT Debt VS Equity VS FCFALTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

ALTI has a Current Ratio of 2.27. This indicates that ALTI is financially healthy and has no problem in meeting its short term obligations.
ALTI has a better Current ratio (2.27) than 70.32% of its industry peers.
A Quick Ratio of 2.27 indicates that ALTI has no problem at all paying its short term obligations.
ALTI's Quick ratio of 2.27 is fine compared to the rest of the industry. ALTI outperforms 70.32% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 2.27
ALTI Yearly Current Assets VS Current LiabilitesALTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

ALTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.04%, which is quite impressive.
The Revenue has grown by 65.81% in the past year. This is a very strong growth!
ALTI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 57.36% yearly.
EPS 1Y (TTM)48.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)65.81%
Revenue growth 3Y57.36%
Revenue growth 5YN/A
Sales Q2Q%8.32%

3.2 Future

The Earnings Per Share is expected to grow by 78.80% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALTI will show a small growth in Revenue. The Revenue will grow by 7.45% on average per year.
EPS Next Y85.43%
EPS Next 2Y126.56%
EPS Next 3Y78.8%
EPS Next 5YN/A
Revenue Next Year0.97%
Revenue Next 2Y6.26%
Revenue Next 3Y7.45%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTI Yearly Revenue VS EstimatesALTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
ALTI Yearly EPS VS EstimatesALTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALTI. In the last year negative earnings were reported.
ALTI is valuated cheaply with a Price/Forward Earnings ratio of 7.48.
ALTI's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALTI is cheaper than 89.95% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, ALTI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.48
ALTI Price Earnings VS Forward Price EarningsALTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALTI Per share dataALTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

ALTI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALTI's earnings are expected to grow with 78.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y126.56%
EPS Next 3Y78.8%

0

5. Dividend

5.1 Amount

ALTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALTI GLOBAL INC

NASDAQ:ALTI (2/21/2025, 8:00:56 PM)

After market: 3.28 0 (0%)

3.28

-0.01 (-0.3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)03-13 2025-03-13/amc
Inst Owners11.13%
Inst Owner Change231.65%
Ins Owners4.16%
Ins Owner Change-0.57%
Market Cap458.64M
Analysts85.71
Price Target9.18 (179.88%)
Short Float %2.54%
Short Ratio10.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-176.47%
Min EPS beat(2)-394.12%
Max EPS beat(2)41.18%
EPS beat(4)1
Avg EPS beat(4)-168.87%
Min EPS beat(4)-394.12%
Max EPS beat(4)41.18%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.17%
Min Revenue beat(2)-6.4%
Max Revenue beat(2)-5.94%
Revenue beat(4)1
Avg Revenue beat(4)0.81%
Min Revenue beat(4)-19%
Max Revenue beat(4)34.6%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-80%
EPS NY rev (1m)0%
EPS NY rev (3m)-140%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.48
P/S 1.55
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)0.44
Fwd EY13.37%
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS2.12
BVpS5.06
TBVpS-1.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.27%
ROE -12.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.66%
ROA(5y)N/A
ROE(3y)-23.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.88%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 2.27
Altman-Z 0.42
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3.51%
Cap/Depr(5y)18.88%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y85.43%
EPS Next 2Y126.56%
EPS Next 3Y78.8%
EPS Next 5YN/A
Revenue 1Y (TTM)65.81%
Revenue growth 3Y57.36%
Revenue growth 5YN/A
Sales Q2Q%8.32%
Revenue Next Year0.97%
Revenue Next 2Y6.26%
Revenue Next 3Y7.45%
Revenue Next 5YN/A
EBIT growth 1Y15.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.75%
EBIT Next 3Y39.96%
EBIT Next 5YN/A
FCF growth 1Y-705.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-637.76%
OCF growth 3YN/A
OCF growth 5YN/A